Prospect: information for the user
duloxetina cinfa 60 mg hard gastro-resistant EFG capsules
duloxetina hydrochloride
Read this prospect carefully before starting to take this medicine, because it contains important information for you.
Contentsof the pack and additional information
duloxetina cinfa contains the active ingredient duloxetina. Duloxetina increases the levels of serotonin and noradrenaline in the nervous system.
Duloxetina is used in adults to treat:
Duloxetina begins to take effect in most people with depression or anxiety within two weeks of starting treatment, but it may take between 2 and 4 weeks to start feeling better. Inform your doctor if you do not notice improvement after this time. Your doctor may continue to give you duloxetina when you are feeling better to prevent your depression or anxiety from returning.
In people with diabetic neuropathic pain, it may take several weeks to start feeling better. Consult your doctor if you do not feel better after 2 months.
Do not take duloxetina cinfa if:
Consult your doctor if you have high blood pressure or a heart condition. Your doctor will tell you if you should take duloxetina.
Warnings and precautions
Duloxetina may not be suitable for you for the following reasons. Consult your doctor or pharmacist before starting to take duloxetina cinfa if:
Duloxetina may cause a feeling of restlessness or inability to sit or stay still. If this happens, tell your doctor.
Some medicines in the same group as duloxetina cinfa (called SSRIs/SNRIs) may cause sexual dysfunction symptoms (see section 4). In some cases, these symptoms persist after stopping treatment.
Thoughts of suicide and worsening of depression or anxiety
If you are depressed and/or have anxiety disorders, you may occasionally have thoughts of self-harm or suicide. These thoughts may be increased at the beginning of treatment with antidepressants, as all these medicines take time to work, usually two weeks but sometimes longer.
It is more likely that you will have these thoughts if:
Contact your doctor or go directly to the hospital if you have any thoughts of self-harm or suicide.
It may be helpful to tell a close friend or family member that you are depressed or have an anxiety disorder, and ask them to read this leaflet. They may be able to tell if your depression or anxiety is getting worse, or if they are concerned about changes in your behaviour.
You should also contact your doctor:
If you experience signs and symptoms of restlessness, hallucinations, loss of coordination, rapid heartbeat, increased body temperature, rapid changes in blood pressure, hyperactive reflexes, diarrhoea, coma, nausea, vomiting, as you may be suffering from a serotonin syndrome.
In its most severe form, serotonin syndrome can resemble Neuroleptic Malignant Syndrome (NMS). The signs and symptoms of NMS may include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased muscle enzymes (determined by blood test).
Children and adolescents under 18 years
Duloxetina is usually not used in children and adolescents under 18 years old. You should also know that patients under 18 years old who take this type of medicine have an increased risk of side effects such as suicidal behaviour, suicidal thoughts, and hostility (mainly aggression, oppositional behaviour, and anger). Despite this, your doctor may prescribe duloxetina to patients under 18 years old because they decide it may be beneficial for the patient. If your doctor has prescribed duloxetina to a patient under 18 years old and you want to talk about it, please go back to your doctor. You should inform your doctor if any of the above symptoms appear or worsen in patients under 18 years old who are taking duloxetina. Additionally, in this age group, the long-term safety effects of duloxetina related to growth, maturation, and cognitive and behavioural development have not yet been demonstrated.
Taking duloxetina cinfa with other medicines
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.
The main component of duloxetina cinfa, duloxetina, is used in other medicines for other treatments:
You should avoid using more than one of these medicines at the same time. Check with your doctor if you are already using other medicines that contain duloxetina.
Your doctor will decide if you can take duloxetina with other medicines.Do not start or stop using any medicine, including those bought without a prescription and herbal remedies, without first consulting your doctor.
You should also inform your doctor if you are taking any of the following medicines:
Monoamine oxidase inhibitors (MAOIs):You should not take duloxetina if you are taking, or have taken in the last 14 days, another antidepressant known as a monoamine oxidase inhibitor (MAOI). For example, moclobemide (an antidepressant) and linezolid (an antibiotic). Taking a MAOI with many prescription medicines, including duloxetina, can cause serious side effects, even life-threatening. You should wait at least 14 days after stopping treatment with a MAOI before taking duloxetina. Similarly, you should wait at least 5 days after stopping treatment with duloxetina before starting treatment with a MAOI.
Medicines that cause drowsiness:This includes prescription medicines prescribed by your doctor, such as benzodiazepines, powerful analgesics, antipsychotics, phenobarbital, and antihistamines.
Medicines that increase serotonin levels:triptans, tramadol, tryptophan, selective serotonin reuptake inhibitors (SSRIs, such as paroxetine and fluoxetine), serotonin-norepinephrine reuptake inhibitors (SNRIs, such as venlafaxine), tricyclic antidepressants (such as clomipramine and amitriptyline), petidina, St. John's Wort, and MAOIs (such as moclobemide and linezolid). These medicines increase the risk of side effects; if you notice any unusual symptoms when using any of these medicines with duloxetina, tell your doctor.
Oral anticoagulants or antiplatelet agents:medicines that thin the blood or prevent the formation of blood clots. These medicines may increase the risk of bleeding.
Taking duloxetina cinfa with food, drinks, and alcohol
Duloxetina can be taken with or without food. You should be careful if you take alcohol while taking duloxetina.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medicine.
Driving and using machines
During treatment with duloxetina, you may feel drowsy or dizzy. Do not drive or operate tools or machines until you know how duloxetina affects you.
duloxetina cinfa contains saccharose.
This medicine contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Duloxetine should be taken orally. Swallow the capsule whole with water.
For depression and diabetic neuropathic pain:
The recommended dose of duloxetine is 60 mg once a day, but your doctor will prescribe the dose that is best for you.
For generalized anxiety disorder:
The initial normal dose of duloxetine is 30 mg once a day, after which most patients will receive 60 mg once a day, but your doctor will prescribe the dose that is best for you. The dose may be adjusted to 120 mg per day depending on your response to duloxetine.
To avoid forgetting to take duloxetine, it may be helpful to take it at the same time every day.
Discuss with your doctor for how long you should take duloxetine. Do not stop taking duloxetine, or change your dose without consulting your doctor. It is essential to treat your condition properly to help you improve. If you do not treat it, your condition may not disappear and may become more severe and harder to treat.
If you take more duloxetine cinfa than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
Among the symptoms produced by an overdose are drowsiness, coma, serotonin syndrome (a rare reaction that can cause a feeling of intense happiness, drowsiness, clumsiness, restlessness, feeling drunk, fever, sweating, or muscle rigidity) seizures, vomiting, and high heart rate.
If you forgot to take duloxetine cinfa
If you forget to take a dose, take it as soon as you remember. However, if it is time for the next dose, skip the missed dose and take a single dose as you normally do. Do not take a double dose to compensate for the missed doses. Do not take more duloxetine than prescribed for you in a day.
If you interrupt the treatment with duloxetine cinfa
DO NOT stop taking your capsules without your doctor's advice, even if you feel better. If your doctor thinks you no longer need to take duloxetine, they will instruct you to reduce your dose for at least 2 weeks before stopping treatment.
Some patients who have stopped duloxetine treatment abruptly have presented symptoms such as:
These symptoms are usually not significant and disappear within a few days, but if you have symptoms that are bothersome, ask your doctor for advice.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. These side effects are usually mild to moderate and often disappear within a few weeks.
Very common side effects (may affect more than 1 in 10 patients)
Common side effects (may affect up to 1 in 10 patients)
Children and adolescents under 18 years of age with depression treated with this medicine experienced a decrease in weight when they started taking this medicine. After 6 months of treatment, their weight levels were similar to those of other children and adolescents of the same age and sex.
Uncommon side effects (may affect up to 1 in 100 patients)
Rare side effects (may affect up to 1 in 1,000 patients)
Very rare side effects (may affect up to 1 in 10,000 patients)
Side effects of unknown frequency (cannot be estimated from available data)
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Store in the original packaging. Do not store at a temperature above 30 °C.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Duloxetina cinfa composition
Appearance of the product and content of the container
Duloxetina cinfa are hard, gastro-resistant capsules presented in aluminum/aluminum blister packs.
The 60 mg capsules are blue and green. Each duloxetine cinfa capsule contains pellets of duloxetine hydrochloride with a coating to protect them from stomach acid.
Duloxetina cinfa 60 mg is available in containers of 28 and 56 capsules.
Only some container sizes may be commercially marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Cinfa, S.A.
Carretera Olaz-Chipi, 10. Industrial Estate Areta
31620 Huarte (Navarra) – Spain
Responsible manufacturer
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona, 69
08970 Sant Joan Despí (Barcelona) – Spain
or
Cinfa, S.A.
Carretera Olaz-Chipi, 10. Industrial Estate Areta
31620 Huarte (Navarra) – Spain
Last review date of this leaflet: August 2024
Further information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.